Drug Resistance

Reduced Susceptibility of S. aureus to Vancomycin - Japan, 1996

Published in Medical Letter on the CDC and FDA, July 28th, 1997

The bacterium Staphylococcus aureus, a common cause of serious and often life-threatening infections in healthy as well as hospitalized adults, is developing increasing resistance to vancomycin, the principal drug used to treat strains already resistant to other available antibiotics.

Recently, a strain of S. aureus with reduced susceptibility to vancomycin was identified as the cause of an infection in a child hospitalized in Japan following surgery. According to the Centers for Disease Control, such strains of S. aureus have not been identified to date in the United States ("Reduced Susceptibility of Staphylococcus aureus to Vancomycin -...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (1997-07-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry